Search research articles
Contact Us
Filters
Showing results (411-420 of 489) with videos related to
Page
of 49
Sort By:
Meditsina Truda I Promyshlennaia Ekologiia
|
January 1, 1993
[Role of health centers in reduction of morbidity in women employed in the construction industry]
V G Riabkova, V E Kazenov, O V Vladimirtsev, et al.
Trials
|
November 19, 2010
Statistical design of personalized medicine interventions: the Clarification of Optimal Anticoagulation through Genetics (COAG) trial
Benjamin French, Jungnam Joo, Nancy L Geller, et al.
Cancer
|
March 1, 1991
Salvage chemotherapy for patients with germ cell tumors. The Memorial Sloan-Kettering Cancer Center experience (1979-1989)
R J Motzer, N L Geller, C C Tan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 1987
Alternating cycles of etoposide plus cisplatin and VAB-6 in the treatment of poor-risk patients with germ cell tumors
G J Bosl, N L Geller, N J Vogelzang, et al.
Genes, Chromosomes & Cancer
|
March 1, 1990
Cytogenetic and molecular analysis of human male germ cell tumors: chromosome 12 abnormalities and gene amplification
F Samaniego, E Rodriguez, J Houldsworth, et al.
Pediatrics
|
April 25, 2019
Mediators of Improved Adherence to Infant Safe Sleep Using a Mobile Health Intervention
Rachel Y Moon, Michael J Corwin, Stephen Kerr, et al.
Cancer Treatment Reports
|
November 1, 1985
Phase II trial of 4'-deoxydoxorubicin in patients with advanced breast cancer
S P Leitner, E S Casper, T B Hakes, et al.
Cell Transplantation
|
November 21, 2001
Survival of macroencapsulated allogeneic parathyroid tissue one year after transplantation in nonimmunosuppressed humans
A Tibell, E Rafael, L Wennberg, et al.
Mbio
|
January 13, 2021
Peptide-Conjugated Phosphorodiamidate Morpholino Oligomers Retain Activity against Multidrug-Resistant Pseudomonas aeruginosa <i>In Vitro</i> and <i>In Vivo</i>
Dina A Moustafa, Ashley W Wu, Danniel Zamora, et al.
Cancer
|
June 1, 1990
Carboplatin, etoposide, and bleomycin for patients with poor-risk germ cell tumors
R J Motzer, K Cooper, N L Geller, et al.
Page
of 49
Search research articles
Search
Showing results (411-420 of 489) with videos related to
Sort By:
Page
of 49
Meditsina Truda I Promyshlennaia Ekologiia
|
January 1, 1993
[Role of health centers in reduction of morbidity in women employed in the construction industry]
V G Riabkova, V E Kazenov, O V Vladimirtsev, et al.
Trials
|
November 19, 2010
Statistical design of personalized medicine interventions: the Clarification of Optimal Anticoagulation through Genetics (COAG) trial
Benjamin French, Jungnam Joo, Nancy L Geller, et al.
Cancer
|
March 1, 1991
Salvage chemotherapy for patients with germ cell tumors. The Memorial Sloan-Kettering Cancer Center experience (1979-1989)
R J Motzer, N L Geller, C C Tan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 1987
Alternating cycles of etoposide plus cisplatin and VAB-6 in the treatment of poor-risk patients with germ cell tumors
G J Bosl, N L Geller, N J Vogelzang, et al.
Genes, Chromosomes & Cancer
|
March 1, 1990
Cytogenetic and molecular analysis of human male germ cell tumors: chromosome 12 abnormalities and gene amplification
F Samaniego, E Rodriguez, J Houldsworth, et al.
Pediatrics
|
April 25, 2019
Mediators of Improved Adherence to Infant Safe Sleep Using a Mobile Health Intervention
Rachel Y Moon, Michael J Corwin, Stephen Kerr, et al.
Cancer Treatment Reports
|
November 1, 1985
Phase II trial of 4'-deoxydoxorubicin in patients with advanced breast cancer
S P Leitner, E S Casper, T B Hakes, et al.
Cell Transplantation
|
November 21, 2001
Survival of macroencapsulated allogeneic parathyroid tissue one year after transplantation in nonimmunosuppressed humans
A Tibell, E Rafael, L Wennberg, et al.
Mbio
|
January 13, 2021
Peptide-Conjugated Phosphorodiamidate Morpholino Oligomers Retain Activity against Multidrug-Resistant Pseudomonas aeruginosa <i>In Vitro</i> and <i>In Vivo</i>
Dina A Moustafa, Ashley W Wu, Danniel Zamora, et al.
Cancer
|
June 1, 1990
Carboplatin, etoposide, and bleomycin for patients with poor-risk germ cell tumors
R J Motzer, K Cooper, N L Geller, et al.
Page
of 49